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Cytomegaloviruses utilize overlapping and embedded reading frames as a way to efﬁciently package
and express all genes necessary to carry out a complex lifecycle. Murine cytomegalovirus encodes a
mitochondrial-localized inhibitor of Bak oligomerization (vIBO) from m41.1, a reading frame that
is embedded within the m41 gene. The m41.1-encoded mitochondrial protein and m41-encoded
Golgi-localized protein have both been implicated in cell death suppression; however, their contribu-
tion to viral infection within the host has not been investigated. Here, we report that mitochondrial-
localized m41.1 (vIBO) is required for optimal viral replication in macrophages and has a modest
impact on dissemination in infected mice. In contrast, Golgi-localized m41 protein is dispensable
during acute infection and dissemination as well as for latency. All together, these data indicate that the
primary evolutionary focus of this locus is to maintain mitochondrial function through inhibition of
Bak-mediated death pathways in support of viral pathogenesis.
& 2012 Elsevier Inc. All rights reserved.Introduction
Cytomegaloviruses (CMVs) are members of Herpesviridae, an
evolutionarily ancient family of double-stranded DNA viruses.
Human CMV (HCMV), a major infectious cause of birth defects
and an important cause of opportunistic disease, and murine CMV
(MCMV), a natural murine pathogen and important model for
HCMV, have complex genomes, encoding over 167 gene products
(Mocarski, 2007). As a part of this large genomic landscape, CMV
employs overlapping and embedded reading frames to express
functions necessary to carry out a complex lifecycle. From a single
genetic locus, MCMV encodes mitochondrial and Golgi-localized
proteins, m41.1 and m41, respectively (Brocchieri et al., 2005;
Brune et al., 2003; Cam et al., 2010). The m41/m41.1 locus is
comprised of the m41.1 open reading frame (ORF) embedded
entirely within the larger, m41 ORF. Functionally, both proteins
have been implicated in suppression of cell death during viral
infection (Brune et al., 2003; Cam et al., 2010).
Programmed cell death is an ancient cell-intrinsic host defense
strategy to limit pathogen replication and spread (Mun˜oz-Pinedo,
2012). Viruses evolved to encode suppressors of death pathways
to sustain cells and facilitate infection in the host (Mocarski et al.,
2011). Large DNA viruses, such as CMVs, are well equipped to
modulate these defense pathways and encode inhibitors of
caspase 8 and other components of the death pathways toll rights reserved.
, CA, USA.prevent signal transduction to downstream effectors. MCMV-
encoded cell death suppressors, in particular, have revealed the
importance of apoptotic (Cicin-Sain et al., 2008; Manzur et al.,
2009) as well as necrotic (Upton et al., 2010, 2012) cell death
pathways in host defense. Due in large part to the evolutionary
conservation of cell death suppressors encoded by beta herpes-
viruses, these studies have facilitated understanding the contri-
bution of cell death suppression in HCMV pathogenesis
(McCormick and Mocarski, 2012).
Viral proteins regulating mitochondrial-mediated cell death
are among the conserved modulatory functions encoded by
HCMV and MCMV (Arnoult et al., 2004; Arnoult et al., 2008;
Cam et al., 2010; Jurak et al., 2008; Norris and Youle, 2008; Poncet
et al., 2004). Stress signals, largely relayed through Bcl-2 family
member proteins, converge upon the mitochondrial membrane
via two pro-apoptotic Bcl-2 family member proteins, Bax and Bak
(Danial and Korsmeyer, 2004). Bax and Bak collaborate to drive
membrane permeabilization, resulting in the release of cyto-
chrome c and other pro-apoptotic factors that activate execu-
tioner caspases, driving apoptosis. HCMV encodes the viral
mitochondrial inhibitor of apoptosis (vMIA) from the UL37x1
gene. vMIA regulates Bax- and Bak-mediated apoptosis (Arnoult
et al., 2004; Karbowski et al., 2006; McCormick and Mocarski,
2012) as well as an HtrA2 serine protease-dependent death
pathway (McCormick et al., 2008). MCMV encodes two separate
inhibitors, one targeting Bax and one targeting Bak. The m41.1
gene product, encoded from the embedded m41/m41.1 locus
introduced above, is a mitochondrial-localized protein that func-
tions as a dedicated viral inhibitor of Bak oligomerization (vIBO)
(Cam et al., 2010), working in parallel with m38.5-encoded vMIA,
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Manzur et al., 2009; Norris and Youle, 2008). These MCMV-
encoded inhibitors of Bax and Bak promote viral replication by
suppressing cell death (Cam et al., 2010; Jurak et al., 2008;
Manzur et al., 2009; McCormick et al., 2005). Inhibition of Bak-
mediated cell death by vIBO inﬂuences the levels of viral replica-
tion in macrophage cell lines but is completely dispensable in
ﬁbroblasts (Cam et al., 2010). The Bax inhibitor, m38.5 (vMIA) has
been studied extensively in tissue culture for its role in facilitating
viral replication in macrophage, ﬁbroblast, and endothelial cells
(Jurak et al., 2008; Manzur et al., 2009; McCormick et al., 2005).
Furthermore, Bax-mediated cell death suppression inﬂuences
virus levels in infected leukocytes during infection of the natural
mouse host (Manzur et al., 2009). These studies highlight the
importance of m41.1-encoded vIBO as well as m38.5-encoded
vMIA in the infection of particular cell types, but also point to the
absolute need to study infection in the natural host.
In contrast to m41.1, the function of the underlying m41 gene
product is unclear. The m41 reading frame encodes a putative
Type II transmembrane protein that localizes to the Golgi appa-
ratus (Brune et al., 2003) and continued to be implicated in cell
death suppression during infection of macrophages even after the
recognition of m41.1 function (Cam et al., 2010). Death pathways
may be initiated extrinsically at the plasma membrane or intrin-
sically through stress signals sensed by cellular organelles,
including the mitochondria as well as the Golgi apparatus (Ferri
and Kroemer, 2001; Hicks and Machamer, 2005). Despite growing
knowledge of death pathways and how different organelles sense
and respond to these pathways, the mechanism of m41 cell death
suppression at the Golgi apparatus during infection remains
unknown because the gene is dispensable for replication in
permissive macrophage as well as ﬁbroblast cell lines (Cam
et al., 2010). However, the role of this gene product has not been
evaluated in infected mice where the full spectrum of replication,
dissemination, and latency places an increased demand for viral
genes that exhibit a modest impact in cell culture.
Cell culture analysis has revealed mechanistic insights into
the m41/m41.1 locus, particularly related to the function of
m41.1-encoded vIBO. However, the contribution of this protein
to the overall viral lifecycle during natural infection has not been
assessed. Furthermore, the overlapping m41 ORF, also implicated
in cell death suppression (Brune et al., 2003), may also contribute
to MCMV pathogenesis and should be evaluated separately. Here,
we show that m41 function, originally implicated as a cell death
suppressor (Brune et al., 2003), is dispensable for cell death
suppression, replication, dissemination, and latency. In contrast,
m41.1-encoded vIBO contributes to both viral replication and
dissemination during acute infection in mice, afﬁrming the con-
tribution of Bak-mediated cell death to host defense and extend-
ing the evaluation to naturally infected mice.Results
m41.1-encoded vIBO is necessary for viral replication in macrophages
Individual mutations were engineered into m41 and m41.1 to
evaluate the function of these gene products individually
(Fig. 1A), employing a strategy of selection/counterselection and
an intermediate Dm41/m41.1-BAC with a KanR/SacB cassette in
place of the entire m41/m41.1 locus. Counterselection replaced
this cassette with point mutations intended to disrupt the
expression of either Golgi-localized m41 protein or m41.1-
encoded vIBO. To generate the m41 mutant virus, an in-frame
stop codon and the insertion of two nucleotides to frame shift and
generate a novel AfeI restriction site were introduced within m41,without affecting the m41.1 (vIBO) ORF. The resultant mutant
virus (m41.StopFS-BAC) retains the m41 reading frame with
potential to produce a truncated, 66 amino acid protein
(Fig. 1A). The truncated m41 protein product lacks the transmem-
brane domain required for localization to the Golgi apparatus
(Brune et al., 2003; Cam et al., 2010). To eliminate the expression
of the embedded m41.1 ORF without disrupting m41 expression,
point mutations were inserted into the three potential start
codons, changing the m41.1 coding sequence from methionine
to a threonine to prevent translation initiation (Fig. 1A). This
mutant virus was called m41.1.DStart-BAC. The introduced point
mutations did not modify the underlying m41 protein sequence
but created an additional PvuI restriction site that was utilized for
screening purposes. MR-BAC, used together with K181-BAC as
control virus in our studies, was generated from m41.StopFS-BAC
by replacing the mutations with a wild-type locus subsequent to
re-inserting the KanR/SacB cassette. The genomic integrity of all
mutant and control BAC clones was assessed by restriction
fragment length polymorphism (RFLP) with ﬁve restriction
enzymes and found to have the correct structure (Fig. 1B and
data not shown). Furthermore, the insertion of the intended
mutations was conﬁrmed by digestion of PCR products ampliﬁed
from the m41/m41.1 locus with AfeI, the restriction site intro-
duced into the m41 mutant, and PvuI, introduced into the m41.1
mutant virus (Fig. 1C). Digestion with AfeI produced two products
of the expected sizes, 0.8 and 0.2 Kbps, from the m41 mutant
virus while the other viruses lacked this restriction site. Similarly,
digestion with PvuI produced two products from the m41.1
mutant virus of the expected sizes, 0.6 and 0.4 Kbps, which were
not observed with the other viruses. Note that the Dm41/m41.1-
BAC PCR product is increased in size due to the insertion of the
large KanR/SacB cassette. Taken together, the viral BAC clones
were found to have the intended structure and mutations.
The replication properties of the m41- and m41.1-deﬁcient
viruses were compared to the parental K181-BAC and derived
MR-BAC as controls. Cells were infected at a low multiplicity of
infection (MOI), 0.05 for ﬁbroblasts, 0.1 for endothelial cells, and
0.5 for macrophages, to yield a similar proportion of cells initially
infected, and total viral yields were determined on different days
post infection (DPI) by plaque assay. As expected (Brune et al.,
2003), these mutant viruses exhibited replication kinetics similar
to control viruses in NIH3T3 ﬁbroblasts (Fig. 2A), although there
was a slight delay in the replication of the vIBO-deﬁcient virus.
Similarly, both mutant viruses demonstrated replication compar-
able to control viruses in SVEC4-10 endothelial cells (Fig. 2B).
Together, these data demonstrate that m41 and m41.1 are
individually dispensable for viral replication in both ﬁbroblast
and endothelial cells.
m41 and m41.1 gene products had a differential impact on
viral replication levels and kinetics in both primary and estab-
lished macrophages (Fig. 2C–E). During infection of the RAW264.7
macrophage cell line, the vIBO-deﬁcient virus produced titers that
were 10- to 50-fold lower than controls (Fig. 2C), implicating
inhibition of Bak-mediated death in efﬁcient viral replication. This
phenotype was even more dramatic in J774A.1 macrophages,
where mutant viral titers were 50- to 1000-fold lower than
K181-BAC or MR-BAC at late times of infection (Fig. 2D). This
phenotype also extended to primary bone marrow-derived
macrophages (BMDM) where mutant viral titers were more than
10-fold lower than controls (Fig. 2E). In contrast, the Golgi-
localized m41 protein appeared to be dispensable for replication
in macrophages. Mutant virus replication was similar to control
viruses in RAW264.7 (Fig. 2C) and J774A.1 (Fig. 2D) macrophage
lines as well as primary macrophages (Fig. 2E). The slight
difference in m41-mutant viral titers in RAW264.7 cells at
7 and 9 DPI (Fig. 2C) was not observed in either J774A.1 or
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Fig. 1. Mutagenesis of the m41/m41.1 locus. (A) Representation of the m41/m41.1 mutations introduced into K181-BAC. The m41/m41.1 locus was replaced with a
KanR-SacB cassette (Dm41/m41.1-BAC) that was used to derive m41.StopFS-BAC and m41.1.DStart-BAC. The marker rescue (MR-BAC) contains a wild-type m41/m41.1
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m41.StopFS-BAC. To mutate m41.1, point mutations were made in the three potential start codons to encode a threonine. Additionally, a diagnostic PvuI restriction site
was inserted. These are silent mutations in m41. (B) Electrophoretic separation of AvrII- and XbaI-digested K181-BAC DNAs on 0.6% agarose as a diagnostic for integrity of
the genomes. (C) Electrophoretic separation of AfeI- and PvuI-digested PCR products generated by ampliﬁcation of the m41/m41.1 locus in each of the derived viruses as a
diagnostic for the intended mutations in m41 or m41.1. ((B) and (C)) K181-BAC (lane 1), Dm41/m41.1-BAC (lane 2), m41.StopFS-BAC (lane 3), m41.1.DStart-BAC (lane 4),
and MR-BAC (lane 5).
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Fig. 2. Replication kinetics in murine ﬁbroblast and macrophage cell lines. (A) NIH3T3 ﬁbroblast, (B) SVEC4-10 endothelial cells, (C) RAW264.7 macrophages, (D) J774
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macrophages were infected at an MOI of 0.5. Total virus was collected at subsequent times post infection. Titers of cell sonicates were determined by plaque assay on
3T3-SA ﬁbroblasts. Each symbol represents the average of three replicate samples. The dotted line indicates the limit of detection.
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together, these data demonstrate that m41.1-encoded vIBO is
necessary for efﬁcient viral replication in macrophages while
Golgi-localized m41 did not have any impact at all, consistent
with an earlier report (Cam et al., 2010).
Inhibition of Bak-mediated death is necessary for maintenance of cell
viability and viral replication
m41.1-encoded vIBO was previously identiﬁed as critical to
viral replication in macrophages and, separately, shown to control
infected cell viability (Cam et al., 2010). While instructive, this
work left open the question of Bak-dependent control of MCMV
replication in macrophages, an important question, given the
apparent speciﬁcity of vIBO and the relatively large deﬁcit in
replication of m41.1.DStart (Fig. 2C–E). As expected from previous
work (Cam et al., 2010), m41.1-encoded vIBO sustained viability
of infected macrophages (Fig. 3A–C). That is, cell viability of
RAW264.7 (Fig. 3A), J774A.1 (Fig. 3B) and primary BMDM
(Fig. 3C) was reduced during m41.1-mutant viral infection com-
pared to controls. Furthermore, when infected with this mutant
virus, Bak/ BMDMs showed restored viability (Fig. 3D), con-
sistent with the Bak-speciﬁcity of vIBO when used to block
apoptosis in MCMV-infected ﬁbroblasts treated with staurospor-
ine (Cam et al., 2010). In addition to eliminating a need for vIBO in
suppressing cell death and extending our current understanding,Bak/ BMDMs also normalized the replication of vIBO-deﬁcient
virus (Fig. 3E and F). This demonstrates that m41.1 (vIBO)
speciﬁcally counteracts Bak-dependent death in macrophages in
order to sustain viral replication. This is the ﬁrst report directly
linking inhibition of Bak-mediated cell death to efﬁcient viral
replication and therefore provides insight into the role of m41.1
during infection.
Finally, Golgi-localized m41 protein, which had been impli-
cated in sustaining macrophage viability when this region was
ﬁrst studied (Brune et al., 2003), does not contribute to viability of
either established macrophage cell lines or primary BMDMs in
our hands (Fig. 3A–C). Therefore, m41 is dispensable for viral
replication and maintenance of cell viability.
Analysis of viral mutants that modulate host cell or host
immune functions may be ﬂeshed out only after analysis in the
natural host animal. While cultured cells provide a useful plat-
form for evaluation of intrinsic host defense pathways, including
those that promote cell survival in the host, the analysis is by
deﬁnition limited to the cell types chosen. In contrast, the viral
lifecycle within the host animal involves replication in additional
cell types as well as cell differentiation states that are not
reﬂected in cultured cells. Because cell culture may not accurately
reﬂect nuances required for virus dissemination and persistence/
latency in the natural host, the studies thus far may not have been
sufﬁcient to uncover all contributions of either gene product.
Therefore, to more fully dissect the contributions of m41 and
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studied further in infected mice.
m41 is dispensable for acute infection in mice
To assess the contribution of Golgi-localized m41 protein to
replication and dissemination in the host, footpad inoculation
was used to initiate infection in BALB/c mice. Footpad inoculation
introduces virus at a site distal to target organs in contrast to
other routes, such as intraperitoneal (IP), intravenous, or intrana-
sal inoculation. Replication at the site of inoculation as well as in
the spleen, liver, lungs and salivary glands was assessed over the
ﬁrst two weeks of infection. This time frame is required for
control virus to reach peak titers in the salivary glands, a key
organ in evaluating MCMV pathogenesis as it is the ﬁnal site
of viral dissemination and source of transmission. Following infec-
tion, the footpad of mice infected with m41-mutant virus showed
patterns of swelling, a well-characterized aspect of footpadinoculation indicating a robust viral chemokine-dependent inﬂam-
matory response (Saederup et al., 2001), as well as replication that
was indistinguishable from control virus (Fig. 4A and data not
shown). Viral levels above the limit of detection for either the
control or mutant were not detected in spleen or liver (data not
shown). However, mutant virus disseminated to salivary glands and
produced titers that increased between 5 and 14 DPI, reaching the
same high levels as control (Fig. 4B).
Salivary gland-derived stocks exhibit signiﬁcantly increased
virulence over tissue culture-derived virus, particularly in terms
of the levels of viral replication in target organs such as the lungs.
This is a well-recognized feature of MCMV (Osborn and Walker,
1971; Selgrade et al., 1981). We utilized salivary gland-derived
stocks in combination with IP inoculation, thereby inducing a
systemic infection, to evaluate the impact of m41 in an organ
other than the salivary gland. Salivary gland-propagated viral
stocks of m41-mutant virus established a productive infection in
the lungs (Fig. 4C) and salivary glands (data not shown), but not
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L.N. Crosby et al. / Virology 436 (2013) 274–283 279in spleen or liver (data not shown), similar to control virus. In
contrast, mutant virus levels in the lungs were not sustained to
the level of control virus after IP inoculation (Fig. 4C), an
observation that was also made following footpad inoculationwith cell culture stock virus (Fig. 4D). It is important to emphasize
that this difference was only observed at late times of infection,
approximately 14 DPI or later, and suggested a consistent inﬂu-
ence of m41 on clearance of virus from lungs, independent of
virus stock or route of inoculation. Despite this behavior, mutant
virus reached the ﬁnal site of dissemination, the salivary glands,
and replicated at levels similar to the control (Fig. 4E). Replication
within the salivary glands appears to be independent of host
strain as mutant virus was detected in this organ at levels similar
to the control in mice on a C57BL/6 background (data not shown),
a mouse strain that controls MCMV through a predominate NK
cell response contrasting with CD8 T cell control in BALB/c mice
(Arase et al., 2002; Brown et al., 2001; Koszinowski et al., 1990;
Lee et al., 2001; Smith et al., 2002). Thus, m41 appears to be
dispensable for acute viral replication and dissemination in the
intact host, independent of mouse strain.
m41 is dispensable for reactivation from latency
Following primary infection, herpesviruses establish latency
for the life of the host. Replication can recur following reactiva-
tion from latency and subsequent progeny can be transmitted to
new hosts. Although MCMV gene products controlling cell fate
may impact this aspect of viral lifecycle, little experimental
analysis has been undertaken in this area. To determine whether
m41 contributes to latency, BALB/c mice were inoculated via the
IP route, and, after 45 days, the spleen and lungs were harvested
and subjected to an explant reactivation assay. Supernatant from
the explant cultures was collected over time to detect reactivated
virus by plaque assay. The m41-mutant virus reactivated almost
as frequently as control virus from explanted spleen (Fig. 5A) or
lung (Fig. 5B), with only one animal failing to reactivate mutant
virus. Importantly, actively replicating virus was not detected in
the spleen, lung or salivary glands when a portion was titered at
the time of explant (data not shown), afﬁrming that virus
harvested from the explant cultures represented reactivated
virus. Thus, m41 is dispensable for latency.
Suppression of Bak-dependent death contributes to acute viral
replication in the host
To investigate suppression of Bak-dependent death on viral
replication and dissemination, BALB/c mice were inoculated IP
with m41.1-mutant virus, and virus in salivary glands and lungs
was titered on 5, 10 or 14 DPI. vIBO-deﬁcient virus exhibited
wild-type levels of replication in the lungs of BALB/c mice at 5 DPI
(Fig. 6A); however, at 10 DPI vIBO-mutant virus titers were
10-fold lower in the lungs than the other viruses (Fig. 6B). This
attenuation was signiﬁcant (po0.01) in comparison to the K181-
BAC at this time. These results indicate that the Bak inhibitor
modestly inﬂuences maintenance of viral replication in the lungs.
In correlation to the lungs, vIBO-mutant virus replication was
modestly compromised in the salivary glands, where levels were
up to 10-fold lower than control viruses at 10 DPI (Fig. 6C) or 14
DPI (Fig. 6D). Parental K181-BAC titers were higher than the other
viruses at 14 DPI in this experiment, although such variation was
not observed in other experiments (see Fig. 2B and E). Despite
these elevated titers of the parental control, vIBO-mutant viral
titers remained signiﬁcantly reduced in the salivary glands in
comparison to all controls (po0.05).
The role of vIBO in dissemination was also analyzed as MCMV
trafﬁcs through the blood to the salivary glands and lungs in a
subset of monocytes that are recruited during infection by a
virally-encoded chemokine (Fleming et al., 1999; Saederup et al.,
2001; Saederup et al., 1999; Stoddart et al., 1994). To investigate
the role of vIBO during dissemination, viremia was analyzed at
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Fig. 5. Evaluation of the role of the m41 during reactivation in BALB/c mice.
6-week-old BALB/c mice were inoculated with 106 PFU via the IP route. Viral
reactivation in the spleen and lung was assessed at 45 DPI. Half of the (A) spleen
and (B) one lung was harvested and further divided in half to create duplicates.
These portions were further diced into smaller pieces and placed in culture.
Supernatents were removed periodically post explant and overlaid onto 3T3-SA
ﬁbroblasts to determine the presence of reactivated virus by detected CPE.
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blood at 5 DPI, the period of peak viremia (Saederup et al., 1999),
as compared to parental K181-BAC (Fig. 6E). Four animals
infected with vIBO-mutant virus had levels of viremia at or below
the limit of detection, while all K181-BAC infected animals had
detectable virus in the blood at this time. Overall, the absence of
vIBO compromised dissemination within the host, consistent with
reduced titers in the lungs and salivary glands.
To determine if the contribution to viral replication in the host
is due to the interaction of vIBO with Bak, we next characterized
the behavior of vIBO-deﬁcient virus in Bak-deﬁcient mice gener-
ated on a C57BL/6129 mixed lineage. Studies in Bak/ BMDM
led us to expect a normalization of the modest defects observed in
BALB/c mice. However, following IP inoculation of B6129SF2/J WT
strain, there was less than a 10-fold difference in mean titer
between m41.1-mutant and control virus in the salivary glands at
14 DPI, a modest difference that remained the same in
Bak-deﬁcient mice (Fig. 6F). It must be noted that this mixed
background creates a setting where the antiviral immune
response is more complicated than reﬂected in either purebred
C57BL/6 or 129 strains as well as in the susceptible BALB/c strain.
The pressures upon MCMV replication in the different host strains
may alter the necessity of vIBO and its interaction with Bak.
Despite these results, the analysis of m41.1/vIBO in BALB/c mice
revealed a role in acute viral replication, thereby promoting
MCMV pathogenesis.Discussion
In this study, we examined the impact of two different gene
products encoded from alternative ORFs within the m41/m41.1
locus: one (m41) expressing a Golgi localized protein of unknown
function and the other (m41.1) encoding vIBO, a suppressor of
Bak-dependent death. vIBO supports efﬁcient viral replication in
macrophages by suppressing Bak-dependent cell death; however,
this activity provides only a modest beneﬁt in enhancing peak
viral levels in lungs and salivary glands in the infected mouse.
The Golgi-localized m41 protein has no impact on replication or
cell death suppression in macrophages and is dispensable for
replication, dissemination, and latency in the host.
Previous investigations (Cam et al., 2010) of Bak suppression
by m41.1 have focused on infection of ﬁbroblasts, a setting in
which m41.1 is dispensable for viral replication. Replication in
macrophages was shown to be dependent upon m41.1 in these
studies; however, the mechanism in which this gene product
supported viral replication remained to be uncovered. Here we
demonstrated that inhibition of Bak-mediated cell death by
m41.1 (vIBO) is necessary for viral replication in primary macro-
phages. These results were generated independent of agents, such
as staurosporine, that induce exogenous apoptosis and therefore
represent a Bak-dependent pathway triggered by natural viral
infection. Taken together with previous observations (Cam et al.,
2010), Bak-triggered cell death appears to be an independent
antiviral host defense mechanism active in macrophages that
must be suppressed by vIBO for virus infection to continue at full
efﬁciency. Although the trigger of death during infection remains
to be established, recent identiﬁcation of the DNA sensor DAI in
virus-induced programmed necrosis (Upton et al., 2012) leaves
open a role for pathogen sensors in the induction of cell death
pathways. Furthermore, an additional note that can be made is
given that RAW264.7 macrophage cells are deﬁcient of apoptosis-
associated speck-like protein containing a carboxy-terminal CARD
(ASC), a crucial component of inﬂammasome signaling (Pelegrin
et al., 2008), our data also indicates that ASC plays no role in the
pathway impacted by vIBO.
Rather, the Bak-dependent impact of vIBO in sustaining
viability during infection of cultured macrophages, combined
with modest impact of vIBO on acute viral titers in salivary
glands, lungs, and blood seems consistent with long-recognized
roles for monocyte-derived macrophages in the pathogenesis of
viral infection (Fleming et al., 1999; Saederup et al., 2001, 1999;
Shanley and Pesanti, 1980; Stoddart et al., 1994). Monocyte-
derived macrophages are responsible for dissemination to the
salivary glands, a site of persistent viral replication and source of
transmission, and also serve as a reservoir for latent CMV (Hanson
and Campbell, 2006). Latent CMV can be found in several organs
throughout the host outside of lymphoid organs, including the
salivary glands and lungs. Upon differentiation to macrophages,
monocyte precursors transition from being a vehicle of viral
maintenance and dissemination to actively producing progeny
virions that infect neighboring cells. Therefore, an impact in
macrophages may alter patterns of replication, dissemination,
and latency. Thus regulation of Bak-mediated death in a subset of
permissive cells, particularly macrophages, contributes to the
overall maintenance of MCMV pathogenesis.
Bak inhibition through vIBO has less of an impact than
Bax inhibition by vMIA, encoded by m38.5 (Arnoult et al., 2008;
Jurak et al., 2008; Manzur et al., 2009; Norris and Youle, 2008),
and neither of these mitochondrial inhibitors impacts viral
pathogenesis as profoundly as the viral caspase 8 inhibitor, vICA
(Cicin-Sain et al., 2008) or the viral RIP inhibitor, vIRA (Upton
et al., 2010, 2012). Given the fact that m38.5 mutants, like the
m41.1 mutant virus described here, inﬂuence viability of infected
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vIBO, respectively, have overlapping roles in cell death suppres-
sion even though they evolved independently in MCMV. HCMV
vMIA, the UL37x1 gene product, while recognized as an inhibitor
of Bax-mediated cell death (Arnoult et al., 2004; Poncet et al.,
2004), also interacts with Bak (Karbowski et al., 2006), further
supporting an overlap in regulation of Bax- and Bak-mediated
death pathways. A full understanding of the contribution that Bax
and Bak, as well as inhibitors that are speciﬁc for these pro-
apoptotic Bcl-2 family members, will likely emerge from further
studies comparing the behavior of MCMV mutant viruses with
individual mutations and the m38.5/m41.1 double mutant.
The role of m41 in MCMV pathogenesis remains an enigma.
Originally, Golgi-localized m41 was implicated in cell deathsuppression, particularly in macrophages (Brune et al., 2003),
but this assignment occurred prior to the recognition of
embedded m41.1-encoded vIBO (Cam et al., 2010). Here we show
that m41 does not contribute to cell death suppression in
cultured ﬁbroblasts, endothelial cells, or macrophages, and that
m41 mutant viral infection in the host is largely indistinguishable
from infection with control viruses. While it is formally possible
that m41 is non-functional in the K181-BAC strain, we favor the
view that m41 may encode a function that is linked to m41.1,
which would only emerge in a study of m41/m41.1 double
mutant virus. Preliminary data suggests that the intermediate
insertion mutant, Dm41/m41.1-BAC, carrying a KanR/SacB cas-
sette, is more attenuated than either independent mutant. How-
ever, because of the potential for this large insertion to alter gene
L.N. Crosby et al. / Virology 436 (2013) 274–283282expression outside of the m41 locus, we believe it is best to
continue to evaluate this separate issue of a combined inﬂuence
of these viral genes with more precisely designed mutations.
Nevertheless, it is possible that m41 localizes to Golgi bodies to
modulate the activity of vIBO at the mitochondria. Therefore,
ongoing research is focused on determining whether m41 and
m41.1 collaborate in any way.
In summary, we have demonstrated that m41.1-encoded vIBO
inﬂuences viral dissemination and replication speciﬁcally in lungs and
salivary glands, sites important in viral pathogenesis and transmis-
sion. A number of issues remain to be resolved, including (i) the cell
type(s) sensitive to Bak-mediated cell death within the host, (ii) the
combined contribution of mitochondrial cell death suppression by
m41.1 (vIBO) and m38.5 (vMIA) to MCMV pathogenesis, and (iii) the
possible interaction between m41 and m41.1 (vIBO) functions.Materials and methods
Cells
NIH3T3 ﬁbroblasts (ATCC CRL-1658), 3T3-SA ﬁbroblasts (ATCC
CCL-92), RAW264.7 macrophages (ATCC TIB-71), and J774A.1
(ATCC TIB-67) were maintained at 37 1C with 5% CO2 in DMEM
containing 4.5 g/mL glucose, 1 mM sodium pyruvate, 10% fetal
bovine serum (Atlanta Biologicals), 2 mM L-glutamine, 100 U/mL
penicillin, and 100 U/mL streptomycin (Invitrogen). Bone
marrow-derived macrophages were harvested from B6129P2
backcrossed to C57BL/6 mice for three generations (referred to as
C57BL/6) and maintained in house as well as B6129-Baxtm2Sjk
Bak1tm1Thsn/J mice (referred to as Bak/) were provided by Douglas
Green (St. Jude Children’s Research Hospital) with permission from
Jackson Laboratories (stock number 006329). Pooled bone marrow
cells were ﬂushed from tibias and femurs and differentiated for
7 days in DMEM containing 20% fetal bovine serum and 10% ﬁltered
L929 medium containing macrophage colony-stimulating factor
(M-CSF). Cells were harvested by scraping, seeded into 48-well plate
at a density of 8.5104 cells per well, and then cultured at 37 1C
with 5% CO2 at least 18 h before infection.
BAC mutagenesis and recombinant viruses
Plasmid pSIM6 encoding the l red recombination functions (Datta
et al., 2006) was introduced into Escherichia coli strain DH10B
harboring the MCMV strain K181 genome (Redwood et al., 2005).
Mutations were introduced in to the m41/m41.1 locus of K181-BAC
via recombineering protocols as previously described (Tandon and
Mocarski, 2008). The following primers were used to insert the
selection/counterselection Kan/SacB cassette: Kan/SacB-F 50 aatagt-
catccgatgatcgtgtcgccgcccgaccgccctcctcccccaattaggcccgtagtctgcaaatcc;
Kan/SacB-R 50 cgccgtttcctcacattccgttgtcgtgcgcaggttcctccgaacctttggaaa-
taccgcacagatgcgtaagg. The Kan/SacB cassette was subsequently
replaced with the m41/m41.1 locus containing point mutations in
m41 (primers: m41.StopFS-F 50 ctccgacgaagatgacagcgcttcctaggaaccgt-
tgtctcc; m41.StopFS-R 50 ttaggagacaacggttcctaggaagcgctgtcatcttcgtcg-
gag; homology region-F 50 tagtcatccgatgatcgtgtcgccgcccgaccgccctcctc
ccccaattcatctgtcaatgatcacga; homology region-R 50 cgccgtttcctca-
cattccgttgtcgtgcgcaggttcctccgaacctttgatgggagacgatgatcgt) or m41.1
(primers: m41.1.DStart-R atgggagacgacgatcgtcgcggcgacggcggcggcata-
cacggctctggctctgcc; homology region-F 50 tagtcatccgatgatcgtgtcgccg-
cccgaccgccctcctcccccaattcatctgtcaatgatcacga; homology region-R
50 tttcctcacattccgttgtcgtgcgcaggttcctccgaacctttgatgggagacgacgatcgtcg-
cggcg). All BAC-derived mutant and parental clones were diagnosti-
cally screened by PCR over the m41/m41.1 locus (primers:
m41/m41.1-F 50 agtcatccgatgatcgtgtcgccgcccgac; m41/m41.1-R
50 ccgaaccggagcaccgtttgcctac) and restriction fragment lengthpolymorphism (RFLP) analysis by ﬁve restriction enzymes. Following
proper genetic characterization of the BAC-derived clones, mutant
and parental viruses were reconstituted by transfection of NIH3T3
ﬁbroblasts. Cell-associated and supernatant virus were collected and
subjected to three rounds of plaque puriﬁcation. Viral isolates were
screened after the ﬁrst round of plaque puriﬁcation for the loss of GFP
signal and repair of m06–m07 following excision of the BAC insert
(Redwood et al., 2005) by PCR (primers: BAC-F 50 ctcaagcgatacgg-
caagcggctc; BAC-R 50 gcgagtgacgggtcgcatccgttag). Following plaque
puriﬁcation, mutant and parental viruses were propagated on NIH3T3
ﬁbroblasts, clariﬁed, concentrated, and titered by plaque assay on
3T3-SA ﬁbroblasts. Salivary gland-derived virus was generated by IP
inoculating BALB/c mice with plaque puriﬁed, tissue culture-derived
K181-BAC orm41.StopFS-BAC virus. Salivary glands were removed 14
DPI following CO2 asphyxiation and placed in 1:1 mixture of DMEM
and sterile milk. Salivary glands were disrupted by sonication and
centrifuged at 2300 g for 10min at 4 1C to clarify the salivary gland/
DMEM portion frommilk mixture. Following clariﬁcation, viral stocks
were stored in DMEM at 80 1C and titered by plaque assay. Growth
curves and viral yields were performed by infecting cells in 24-well
plates at the indicated multiplicity of infection (MOI) in 0.25 mL for
1 h at 37 1C. Following adsorption, the viral inoculum was replaced
with complete DMEM. Samples were harvested at the indicated times
and titered by plaque assay.
Cell viability assay
Cells (20,000 cells/well) were seeded into 96-well plate in
quadruplicate. Approximately 18 h post seeding, medium was
replaced with 50 ml of virus inoculum containing 10 PFU/cell (MOI
10). At the indicated times, cell viability was determined by
measuring the ATP levels using the Cell Titer-Glo Luminescent
Cell Viability Assay kit (Promega) according to manufacture’s
protocol.
Mice, infections, and organ harvests
BALB/c mice were obtained from Jackson Laboratory. B6
129-Baxtm2Sjk Bak1tm1Thsn/J mice in combination with B6129SF2/J
mice (Jackson Laboratory) were used for in vivo experiments. Five
to eleven-week old mice were inoculated in one hind footpad or
IP with either 104 PFU of salivary gland-derived virus or 106 PFU
of tissue culture-derived virus as previously described (Saederup
et al., 2001). The inoculum titers were conﬁrmed after thaw at the
onset of animal experiments. At the time of sacriﬁce, organs were
placed in 1 mL of complete DMEM and stored at 80 1C until
thawed, disrupted by sonication, and titered by plaque assay.
Peripheral blood leukocytes (PBL) were isolated from blood
collected via heart puncture in syringes loaded with 0.5 M EDTA
(Cellgro). Blood was diluted in PBS, layered onto Histopaque-119
(Sigma) density medium, and centrifuged (30 min, 700 g, 25 1C).
Cells within the band at the plasma-Histopaque interface were
removed and washed in PBS. Erythrocytes were lysed in a solution
containing 1.5 M NH4Cl2, 0.1 M NaHCO3, and 0.01 M Na2-EDTA.
Viable cells were counted on a hemacytometer using trypan blue
exclusion and evenly divided into three tubes contained 1 mL
DMEM. PBL/DMEM suspensions were overlaid onto 3T3-SA ﬁbro-
blasts to perform an infectious center assay.
Latent infection and explant reactivation
For latent infections and explant reactivation, BALB/c mice
were inoculated with 106 PFU by IP injection. At the time of
sacriﬁce, one lung and half the spleen were collected for evalua-
tion by plaque assay in order to detect actively replicating virus.
The other lung and half of spleen were used to establish explant
L.N. Crosby et al. / Virology 436 (2013) 274–283 283cultures in duplicate as previously described (Stoddart et al.,
1994). Virus titers were assessed at weekly intervals in the
culture supernatants by plaque assay.Acknowledgements
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